PSMA-Targeted Radiopharmaceuticals for Prostate Cancer Diagnosis and Therapy
{{output}}
Prostate cancer (PCa) is the most common noncutaneous malignancy in men. Until recent years, accurate imaging of men with newly diagnosed PCa, or recurrent or low-volume metastatic disease, was limited. Further, therapeutic options for men with advanced, metas... ...